NRx Pharmaceuticals Withheld COVID-19 Drug Approval Info from Investors, Class Action Alleges
January 19, 2022 A class action alleges NRx Pharmaceuticals was not forthcoming to investors with regard to the prospects of a purported COVID-19 treatment being approved for emergency use.